Compare medications

Max 4 meds. Sources include DailyMed labels; verify against official labeling. Last reviewed shown per row. On small screens the table defaults to a compact view—use “Show all columns” to view everything (scroll horizontally). Visit individual drug pages for narratives, printable summaries, and therapeutic drug monitoring notes.

Add up to 4 medications

0/4 selected

Browse catalog

Oral Antipsychotics

Second Generation Antipsychotics (SGAs)

First Generation Antipsychotics (FGAs)

Long‑acting Injectable Antipsychotics (LAIs)

Mood Stabilizers

Adjunctive Medications

Ketamine & rapid-acting antidepressants (2)

Benzodiazepines (12)

Sleep & circadian agents (14)

ADHD & wakefulness agents (14)

Substance use treatment & harm reduction (11)

Metabolic & weight management (4)

Other adjunctive medications (17)

Compact view hides Indications, MOA, PK, TDM, Monitoring, and Reviewed.

Medication	Indications (label)	Dosing highlights	MOA	PK	TDM	Risk flags	Monitoring	LAI options	Last reviewed
oxazepamAdjunctive therapy View labelExact	Management of anxiety disorders / short-term relief of anxiety symptoms; and alcohol withdrawal symptoms (label). View labelExact	Dosing is divided and varies by indication and symptom severity; lowest-effective dosing for the shortest feasible duration is typical (label). Older patients require cautious dosing to reduce oversedation and falls (label).	Benzodiazepine; GABA-A receptor positive allosteric modulator.	Glucuronidation \| Single-dose mean 8.2 h; Single-dose range 5.7–10.9 h	No	Sedation	Reassess indication and symptom trajectory at each renewal; avoid chronic maintenance without a clear goal. Screen for opioid co-prescribing, alcohol use, sleep apnea/COPD, and fall risk before prescribing. Monitor for oversedation, confusion, and impaired coordination; adjust dose or discontinue if harms outweigh benefit. If used beyond a short course, document a gradual taper plan and monitor for withdrawal.	No	2025-12-29
lorazepamAdjunctive therapyBrands: ATIVAN, LOREEV XR View labelExact	Anxiety disorders; insomnia due to anxiety/stress (label varies by product). View labelExact	Anxiety (label ranges vary): typically 1–3 mg/day in divided doses; titration is typically cautious based on sedation and fall risk.	Benzodiazepine; positive allosteric modulator of GABA-A receptors.	Glucuronidation \| Single-dose mean 12 h	No	Sedation	Functional benefit and safety are reassessed at each renewal; open-ended continuation without documented goals is generally avoided. Sedation, falls, and driving impairment are monitored—especially in older adults and when other CNS depressants are present. For catatonia, follow-up is often frequent, with coordinated escalation pathways (medical evaluation and ECT readiness when response is incomplete). If discontinuing after more than brief use, gradual tapering and monitoring for withdrawal symptoms and rebound anxiety are typical.	No	2025-12-28
diazepamAdjunctive therapyBrands: VALIUM View labelExact	Anxiety disorders (label); also used for alcohol withdrawal, muscle spasm, and seizures (label varies by product). View labelExact	Anxiety (label ranges vary): the lowest effective dose is typically used in divided doses; dose escalation is generally avoided without a clear, time-limited plan. Alcohol withdrawal and seizure protocols vary by setting; coordination with medical teams and close monitoring of vitals and sedation are typical.	Benzodiazepine; positive allosteric modulator of GABA-A receptors.	CYP3A4, CYP2C19 \| Single-dose range 20–48 h	No	Sedation	Functional benefit and safety at each renewal; open-ended continuation without documented goals is generally avoided. Sedation, falls, and driving impairment—especially in older adults and when other CNS depressants are present. Screening for substance use disorders and prescription monitoring data review; aligning on a single prescriber and pharmacy is common. If discontinuing after more than brief use, tapering is gradual with monitoring for withdrawal symptoms and rebound anxiety.	No	2025-12-28
alprazolamAdjunctive therapyBrands: XANAX, XANAX XR View labelExact	Anxiety disorder and panic disorder (label). View labelExact	Dosing is typically kept at the lowest effective dose for the shortest feasible duration; dose escalation without a clear target symptom and reassessment plan is avoided. For courses beyond a few weeks, clinicians typically taper gradually; abrupt discontinuation increases withdrawal and seizure risk.	Benzodiazepine; positive allosteric modulator of GABA-A receptors.	CYP3A4 \| Single-dose mean 11.2 h; Single-dose range 6.3–26.9 h	No	Sedation	Functional benefit and safety should be reassessed at each renewal; avoid open-ended continuation without documented goals. Substance use screening and prescription monitoring review are commonly used; a single prescriber and pharmacy plan can reduce misuse risk. Monitor sedation, falls, and driving impairment—especially in older adults and when other CNS depressants are present. If discontinuing after more than brief use, taper gradually and monitor for withdrawal symptoms and rebound anxiety.	No	2025-12-28

Compare tool FAQ

How many medications can I compare at once?

You can line up to four medications at a time. Use the search box to add or remove drugs, then press “Compare” to refresh the table.

Where does the comparison data come from?

Most fields are generated from our curated facts + per-drug profiles. DailyMed label links come from source metadata, and LAI options come from our LAI catalog.

Can I save or share a comparison?

Yes. The Share button copies a link you can send to teammates, and we store your most recent selection so you can restore it next time you visit.